aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

Go back to aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Life Technologies Corporation (NASDAQ: LIFE) Delayed: 38.55 --0 (-0%)
Previous Close $38.55    52 Week High $10.93 
Open $38.55    52 Week Low $2.48 
Day High $38.55    P/E 14.23 
Day Low $38.55    EPS $2.71 
Volume 27